Publications by the researcher in collaboration with P. Esbrit Arguelles (9)

2017

  1. Oxidation inhibits PTH receptor signaling and trafficking

    Biochemical and Biophysical Research Communications, Vol. 482, Núm. 4, pp. 1019-1024

2010

  1. Comparative in vitro effects of soybean isoflavones and resveratrol on human osteoblastic cells

    Isoflavones: Biosynthesis, Occurrence and Health Effects (Nova Science Publishers, Inc.), pp. 181-194

2009

  1. Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells

    Life Sciences, Vol. 85, Núm. 11-12, pp. 421-430

2008

  1. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2

    Journal of Cellular Physiology, Vol. 217, Núm. 3, pp. 717-727

  2. Receptor activator of nuclear factor-κB ligand (RANKL) as a novel prognostic marker in prostate carcinoma

    Histology and Histopathology, Vol. 23, Núm. 6, pp. 709-715

2007

  1. Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: Relative chanqes or parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand

    Journal of Clinical Pathology, Vol. 60, Núm. 3, pp. 290-294

2006

  1. Diferentes dosis de los fitoestrógenos genisteína y daidzeína afectan de distinto modo a la viabilidad celular y a la expresión de factores implicados en el desarrollo del cáncer de próstata

    Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 15, Núm. 5, pp. 91-97

  2. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro

    Calcified Tissue International, Vol. 79, Núm. 5, pp. 360-369

2005

  1. Efectos moduladores de los fitoestrógenos sobre la diferenciación de osteoblastos humanos

    Mapfre medicina, Vol. 16, Núm. 3, pp. 174-183